P. Ge

Suppression of Somatic Expansion As a Novel Therapeutic Approach for Huntington Disease and Other Repeat Expansion Disorders

S. Tabrizi, B. Bettencourt, G. Marnellos, 2022, GEN Biotechnology.

Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains

M. MacDonald, J. Gusella, J. Vonsattel, 1994, Neurobiology of Disease.

Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease

M. DiFiglia, J. Vonsattel, E. Bird, 1995, Neuroscience.

Inactivation of the mouse Huntington's disease gene homolog Hdh.

A. Joyner, J. Gusella, J. Vonsattel, 1995, Science.

Normal and Expanded Huntington’s Disease Gene Alleles Produce Distinguishable Proteins Due to Translation Across the CAG Repeat

M. MacDonald, J. Gusella, J. Vonsattel, 1995, Molecular medicine.

Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals

M. MacDonald, J. Penney, A. Young, 1995, Annals of neurology.

Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis

J. Penney, A. Young, J. Vonsattel, 1995, Neuroscience.

IT15 gene expression in fetal human brain

G. Bernhard Landwehrmeyer, James F. Gusella, Marcy E. MacDonald, 1994, Brain Research.